Biopsy‐Sparing Diagnosis of Coeliac Disease Based on Endomysial Antibody Testing and Clinical Risk Assessment
Low-risk adult patients could have been safely diagnosed with coeliac disease non-invasively based on EmA without endoscopy and duodenal biopsy. Older patients with alarm symptoms should undergo endoscopy with duodenal biopsy to avoid missing non-coeliac enteropathies. Further validation of our results is necessary.
Authors
- Paolo Minerba (ORCID: https://orcid.org/0009-0002-5858-1269)
- Stiliano Maimaris (ORCID: https://orcid.org/0000-0003-2057-8179)
- Annalisa Schiepatti (ORCID: https://orcid.org/0000-0002-8493-7698)
- Ignazio Marzio Parisi
- Daniel Ignacio Conforme Torres
- Giovanni Arpa (ORCID: https://orcid.org/0000-0001-7226-381X)
- Federico Biagi (ORCID: https://orcid.org/0000-0002-2227-4622)
- Roberta Muscia
- Virginia Gregorio
- Chiara Scarcella (ORCID: https://orcid.org/0000-0002-2538-0930)
- Carolina Cicalini
- Claudia Delogu
- Michele Dota
- Giulio Massetti
Institutions
- University of Pavia (IT)
- Istituti Clinici Scientifici Maugeri (IT)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1111/apt.70129
- Citations
- 4
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 7.24